Jin Hai Medical (02225) was awarded the "Most Valuable Pharmaceutical and Medical Company" in Jin Gang Stocks, with frequent highlights throughout the year.

At the "Ninth GMTEight Capital Market Annual Conference and Listed Company Awards Ceremony", Today's Health Medical (02225) was awarded the honor of "Most Valuable Pharmaceutical and Medical Company." As a highly regarded company in the industry, Today's Health Medical has won widespread recognition from investors for its outstanding technological innovation and market performance. The "Most Valuable Pharmaceutical and Medical Company" award recognizes pharmaceutical and medical companies listed on the Hong Kong and American stock markets with healthy corporate governance structures, significant industry positions, strong core businesses, and the ability to provide investors with sustainable and stable value returns. Today's Health Medical's receipt of the "Most Valuable Pharmaceutical and Medical Company" award not only recognizes the company's efforts over the past year but also signifies its continued leadership in industry development and promotion of the application of more innovative achievements in the future. As a medical technology company focusing on the high-end endoscope field, Today's Health Medical has gradually become a well-known brand in the industry with its strong research and development capabilities and innovation in the field of minimally invasive surgical solutions and related medical products and services. Looking back on the past year, Today's Health Medical has achieved significant progress in technological innovation, with breakthroughs in its products. Breakthroughs in technological innovation have been widely recognized by the market Today's Health Medical focuses on the high-end endoscope field and has built a good reputation in minimally invasive surgical solutions and related medical products and services through its strong research and development capabilities and innovation. Of particular note is the Endo Next series true 4K 3D 4MOS ultra-high-definition fluorescence endoscope system launched by the company in July 2023, which not only integrates "4K+3D+fluorescence" triple technology but also introduces the world's first AI voice control function, greatly enhancing operational simplicity and application safety. On the technological front, Today's Health Medical's three-dimensional image generator adds depth perception to the converted digital two-dimensional images through software algorithms, resulting images are clearer than traditional arthroscopic images, with a wider field of view, and better visual depth of field. It has become a significant breakthrough in the domestic medical device field. The system was selected for the 2023 Shanghai Innovative Medical Management Instrument Application Demonstration Project, validating its technological value. Moreover, the system has obtained a Class II medical device license from the Shanghai Food and Drug Administration and has multiple successful practical application cases. Leveraging its deep accumulation in endoscope technology, Today's Health Medical has also expanded into the field of percutaneous endoscopic lumbar discectomy and spine minimally invasive surgery this year. With the goal of diversifying its products and applications in the endoscopic field, enriching its product line and application departments, and providing patients with higher-quality treatment options. In terms of technological reserves, Today's Health Medical currently holds over 60 patents, over 20 trademarks, and more than 30 ongoing projects, demonstrating its strong capabilities in technological innovation and intellectual property protection. In the era of "Minimally Invasive 4.0," Today's Health Medical is at the forefront of basic technology, owning technologies such as three/four-chip, naked eye 3D, 4K, 3D, and fluorescence. In the current rapid development of AI, Today's Health Medical is actively promoting research and development technology towards "Minimally Invasive 5.0," focusing on molecular probes, multispectral, intelligent navigation, AI, AR enhancement, and infrared, among others. Thanks to Today's Health Medical's outstanding research and development capabilities, the company has received many honors widely recognized by the market. Specifically, Today's Health Medical's "4K fluorescence naked eye 3D intelligent navigation endoscope system" was selected as one of the top ten national medical equipment renewal solutions in the 15th "China Good Medical Device Evaluation" in 2024. The company's endoscope project also won the "Most Investment Value Award" in the tenth China Medical Industry Innovation Competition. In addition, with the project "4K naked eye 3D fluorescence intelligent navigation endoscope system," Today's Health Medical topped the "2024 Medical Device Innovation Gem Seed List TOP10" in the Chinese health industry. Significantly increased performance, stock prices soared nearly 2.5 times against the trend Technological innovation ultimately reflects on the financial level. In terms of finance, Today's Health Medical's performance has also been impressive. In the first half of this year, the company's revenue reached 25.937 million Singapore dollars, a significant increase of 116.45% year-on-year, demonstrating strong market demand and product competitiveness. The excellent performance has also driven the continuous rise in Today's Health Medical's stock price. It is understood that the Hang Seng Healthcare Index has been under pressure in recent years, with a cumulative decline of 15.27% since the beginning of this year, while Today's Health Medical's stock price has soared nearly 2.5 times, creating substantial returns for investors. In the past year, Today's Health Medical has been highly recognized by the capital market and the industry for its outstanding performance and technological innovation in the high-end endoscope field. Looking ahead to the future, Today's Health Medical will continue to deepen its research in the endoscope field, develop more innovative products, improve medical standards, and provide patients with higher-quality treatment options.